HomeClinical Trial Updates

Clinical Trial Updates

Clinical trial updates

AbbVie booth at the 2019 annual meeting of the American Society of Clinical Oncology (ASCO) held June 1 - 4, 2019 in Chicago, Ill.

U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia

Editorial Team-October 16, 2020

ESMO 2020: Durvalumab Demonstrates Sustained Overall Survival in Unresectable Stage III NSCLC

ESMO 2020: Olaparib Improves Median Time Without Disease Progression in BRCAm Ovarian Cancer

ARAMIS Study Show Significantly Longer Overall Survival with Darolutamide in Non-metastatic CRPC

Adjuvant Dabrafenib + Trametinib in Resected Stage III Melanoma w/BRAF Mutations: 5-Year Follow-up

Woman with lung cancer during medical visit

Tepotinib Shows Activity in Advanced NSCLC with a MET Exon 14...

Peter Hofland, Ph.D-September 10, 2020

Silverback Therapeutics Initiates Phase I clinical study of SBT6050

Editorial Team-September 5, 2020

Study Shows Benefit of Camrelizumab + Cisplatin and Gemcitabine in Nasopharyngeal...

Editorial Team-August 19, 2020

Study Evaluates Diagnostic Value of the Karius Test for Pneumonia in...

Editorial Team-August 3, 2020

$Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory Hodgkin Lymphoma$

Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory...

Editorial Team-July 24, 2020

Accelerated Approval for Kite’s Brexucabtagene Autoleucel in R/R Mantle Cell Lymphoma

Peter Hofland, Ph.D-July 24, 2020

Featured Image: Genmab's Hybridoma and tissue Culture Laboratory. Photo courtesy: 2020 Genmab

Tisotumab Vedotin Shows Positive Results in Phase II Trial in Cervical...

Peter Hofland, Ph.D-June 29, 2020

General view of the 55th Annual Meeting of the American Society of Oncology (ASCO). Courtesey: 2019 ? ASCO/Kristen Norman 2019.

ASCO 2020: Oncoceutics’ ONC201 Demonstrates Clinical Benefit

Peter Hofland, Ph.D-May 30, 2020

Thoughtful young women suffering from ovarian cancer.

FORWARD II Trial of Mirvetuximab Soravtansine + Bevacizumab Demonstrates Encouraging Outcomes

Peter Hofland, Ph.D-May 29, 2020

GlaxoSmithKline (GSK). Photo Courtesy: © 2020 GSK

What to Expect at ASCO 2020: GSK’s Transformational Medicines

Peter Hofland, Ph.D-May 28, 2020

12 3...23 Page 1 of 23

LATEST NEWS

The History, Reality and Promise of Immunotherapy for Cancer

Daniel A. Vorobiof, MD-February 25, 2021

Study Shows Investment is Desperately Needed to Bring Down Pancreatic Cancer Death Rates in...

Editorial Team-February 22, 2021

Improving Lung Cancer Patient Access to Comprehensive Biomarker Testing

Danielle Garcia-February 18, 2021

Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’

Eric T. Rosenthal-February 13, 2021

How Good Communication and Transparency may Help avoid a Medical Malpractice Lawsuits

Peter Hofland, Ph.D-February 10, 2021

Press Releases | Cancer

Current Liver Cancer Screenings May Leave African Americans at Greater...February 25, 2021
Early detection could reduce the number of African Americans dying from liver cancer, but current screening guidelines may not find cancer soon enough in this community, according to a study published...(PRWeb February 25, 2021)Read the full story at https://www.prweb.com/releases/current_liver_cancer_screenings_may_leave_african_americans_at_greater_risk/prweb17756624.htm
Early colorectal cancer detection critical for those over 45February 24, 2021
ASCRS calls for increase in screening leading up to National Colorectal Cancer Awareness Month.(PRWeb February 24, 2021)Read the full story at https://www.prweb.com/releases/early_colorectal_cancer_detection_critical_for_those_over_45/prweb17753894.htm
Using Cognitive Assessment to Improve Decision Making in Oncology...February 23, 2021
In this free webinar, attendees will learn about the assessment of cognition in people with cancer entering clinical trials and how to leverage digital technologies to drive sensitive, reliable and...(PRWeb February 23, 2021)Read the full story at https://www.prweb.com/releases/using_cognitive_assessment_to_improve_decision_making_in_oncology_clinical_trials_upcoming_webinar_hosted_by_xtalks/prweb17746774.htm

Clinical Trial Updates

U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia

ESMO 2020: Durvalumab Demonstrates Sustained Overall Survival in Unresectable Stage III NSCLC

ESMO 2020: Olaparib Improves Median Time Without Disease Progression in BRCAm Ovarian Cancer

ARAMIS Study Show Significantly Longer Overall Survival with Darolutamide in Non-metastatic CRPC

Adjuvant Dabrafenib + Trametinib in Resected Stage III Melanoma w/BRAF Mutations: 5-Year Follow-up

Tepotinib Shows Activity in Advanced NSCLC with a MET Exon 14...

Silverback Therapeutics Initiates Phase I clinical study of SBT6050

Study Shows Benefit of Camrelizumab + Cisplatin and Gemcitabine in Nasopharyngeal...

Study Evaluates Diagnostic Value of the Karius Test for Pneumonia in...

Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory...

Accelerated Approval for Kite’s Brexucabtagene Autoleucel in R/R Mantle Cell Lymphoma

Tisotumab Vedotin Shows Positive Results in Phase II Trial in Cervical...

ASCO 2020: Oncoceutics’ ONC201 Demonstrates Clinical Benefit

FORWARD II Trial of Mirvetuximab Soravtansine + Bevacizumab Demonstrates Encouraging Outcomes

What to Expect at ASCO 2020: GSK’s Transformational Medicines

LATEST NEWS

The History, Reality and Promise of Immunotherapy for Cancer

Study Shows Investment is Desperately Needed to Bring Down Pancreatic Cancer Death Rates in...

Improving Lung Cancer Patient Access to Comprehensive Biomarker Testing

Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’

How Good Communication and Transparency may Help avoid a Medical Malpractice Lawsuits

The History, Reality and Promise of Immunotherapy for Cancer

Study Shows Investment is Desperately Needed to Bring Down Pancreatic Cancer Death Rates in...

Improving Lung Cancer Patient Access to Comprehensive Biomarker Testing

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...